Treatment patterns in patients with pulmonary arterial hypertension

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/104303
• EU PAS number:
  EUPAS104302
• Study ID:
  104303
• Official title and acronym:
  Treatment patterns in patients with pulmonary arterial hypertension
• DARWIN EU® study:
  No
• Study countries:
  Germany

  United Kingdom
• Study description:
  A cohort study to investigate the actual treatment patterns for patients with Pulmonary Arterial Hypertension (PAH) in Germany and the UK, describing (1) the first line treatment for patients diagnosed with PAH focusing on ERA and PDE5i classes (monotherapy or combined), and (2) after how long patients initiating single therapy receive a second drug (combination therapy).
• Study status:
  Finalised

Research institutions and networks

Institutions

European Medicines Agency (EMA)

Study timelines

Date when funding contract was signed

Planned: 31/01/2022

Actual: 31/01/2022

Study start date

Planned: 31/01/2022

Actual: 31/01/2022

Date of final study report

Planned: 15/02/2022

Actual: 08/02/2022

Sources of funding

EMA

Study protocol

Initial protocol

Final Analysis Plan_Treatment patterns in PAH -To be published_CLEAN

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable